Free Standard UK Delivery Over £10 | Free Delivery Europe Over £25

Transforming Big Pharma: Assessing the Strategic Alternatives

Be the first to review this product

In Transforming Big Pharma John Ansell addresses critically how strategy works in the pharmaceutical industry. The long-standing dearth of new products has led to a growing shortfall in revenues. Ansell assesses the wide range of alternative strategies big pharma companies have been pursuing in recent years in attempting to overcome this. He shows that there is sound evidence to expect the recent upturn in the number of new products reaching the market to go on to greater heights. Chapters assess the complex trends in attrition rates, show how rife spectacular sales underestimation in the industry remains, and explain how conventional wisdom on the chances of product profitability also seriously undersells the industry. The surest route to transforming the prospects for big pharma, Ansell contends, is to step up activity in acquiring and developing new products. This is now realistic because, as he shows, the amount of intellectual property available is much greater than it was a decade ago. Ansell believes that no other strategies have sufficient transformative powers, though they may be useful as a stopgap whilst the sales of forthcoming new products mature. He argues for a reversal of big pharmaâ

Availability: In stock

Only 1 left
£85.99
£85.99

In stock books dispatched within 24 hours. Read more...

Ask a question? Call, Email or Skype now.

30 days returns policy. Guaranteed!.

It's good to share!

Additional Information

Additional Information

Author John Ansell
Binding Hardcover
Condition New
Pages 284
ISBN-13 9781409448273
Publisher Routledge

Reviews

Write Your Own Review

You're reviewing: Transforming Big Pharma: Assessing the Strategic Alternatives

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.